Tg Therapeutics (TGTX) Consolidated Net Income: 2016-2025
Historic Consolidated Net Income for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $390.9 million.
- Tg Therapeutics' Consolidated Net Income rose 10006.23% to $390.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $447.5 million, marking a year-over-year increase of 3212.81%. This contributed to the annual value of $23.4 million for FY2024, which is 84.52% up from last year.
- Latest data reveals that Tg Therapeutics reported Consolidated Net Income of $390.9 million as of Q3 2025, which was up 1,286.84% from $28.2 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Consolidated Net Income ranged from a high of $390.9 million in Q3 2025 and a low of -$94.0 million during Q4 2021.
- Moreover, its 3-year median value for Consolidated Net Income was $5.1 million (2025), whereas its average is $41.8 million.
- As far as peak fluctuations go, Tg Therapeutics' Consolidated Net Income tumbled by 96.60% in 2024, and later spiked by 10,006.23% in 2025.
- Quarterly analysis of 5 years shows Tg Therapeutics' Consolidated Net Income stood at -$94.0 million in 2021, then climbed by 14.49% to -$80.4 million in 2022, then surged by 82.07% to -$14.4 million in 2023, then soared by 261.92% to $23.3 million in 2024, then surged by 10,006.23% to $390.9 million in 2025.
- Its Consolidated Net Income was $390.9 million in Q3 2025, compared to $28.2 million in Q2 2025 and $5.1 million in Q1 2025.